Cargando…

Predisposing factors for increased cortisol levels in oral cancer patients

Cancer patients may have a dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and abnormal secretion of cortisol. Increased cortisol levels have been associated with worse prognosis in patients with different types of tumors. Although anxiety and depression can trigger an abnormal cortis...

Descripción completa

Detalles Bibliográficos
Autores principales: Figueira, Jéssica Araújo, Sarafim-Silva, Bruna Amélia Moreira, Gonçalves, Gislene Maria, Aranha, Laerte Nivaldo, Lopes, Flávia Lombardi, Corrente, José Eduardo, Biasoli, Éder Ricardo, Miyahara, Glauco Issamu, Bernabé, Daniel Galera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216328/
https://www.ncbi.nlm.nih.gov/pubmed/35755918
http://dx.doi.org/10.1016/j.cpnec.2022.100110
_version_ 1784731396648992768
author Figueira, Jéssica Araújo
Sarafim-Silva, Bruna Amélia Moreira
Gonçalves, Gislene Maria
Aranha, Laerte Nivaldo
Lopes, Flávia Lombardi
Corrente, José Eduardo
Biasoli, Éder Ricardo
Miyahara, Glauco Issamu
Bernabé, Daniel Galera
author_facet Figueira, Jéssica Araújo
Sarafim-Silva, Bruna Amélia Moreira
Gonçalves, Gislene Maria
Aranha, Laerte Nivaldo
Lopes, Flávia Lombardi
Corrente, José Eduardo
Biasoli, Éder Ricardo
Miyahara, Glauco Issamu
Bernabé, Daniel Galera
author_sort Figueira, Jéssica Araújo
collection PubMed
description Cancer patients may have a dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and abnormal secretion of cortisol. Increased cortisol levels have been associated with worse prognosis in patients with different types of tumors. Although anxiety and depression can trigger an abnormal cortisol secretion, little is known regarding the influence of these emotional disorders on HPA axis dysregulation in cancer patients when evaluating together with demographic, clinicopathological and biobehavioral variables. This cross-sectional study analyzed the pre-treatment plasma cortisol levels of 133 patients with oral squamous cell carcinoma (OSCC) and its association with demographic, clinicopathological, biobehavioral and psychological variables. Plasma cortisol levels were measured by electrochemiluminescence, and anxiety and depression symptoms were assessed using Beck Anxiety Inventory (BAI) and Depression (BDI), respectively. Demographic, clinicopathological and biobehavioral data were collected from patients' medical records. Results from multivariate analysis showed that the occurrence of cancer-induced pain was predictive for higher cortisol levels (OR = 5.388, p = 0.003). Men with OSCC were 4.5 times more likely to have higher plasma cortisol levels than women (OR = 4.472, p = 0.018). The effect of sex on cortisol concentrations was lost in the adjusted model for clinical staging (OR = 2.945, p = 0.116). The absence of chronic alcohol consumption history was a protective factor for highest hormone concentrations in oral cancer patients (OR = 0.104, p = 0.004). Anxiety symptoms measured by BAI as “hands trembling” (OR = 0.192, p = 0.016) and being “nervous” (OR = 0.207, p = 0.0004) were associated with lower cortisol levels. In contrast, the feeling of “fear of losing control” was a risk factor for highest hormone concentrations (OR = 6.508, p = 0.0004). The global score and specific symptoms of depression measured by the BDI were not predictive for plasma hormone levels (p > 0.05). Together, our results show that pain, alcohol consumption and feeling fear are independent factors for increased systemic cortisol levels in patients with oral cancer. Therefore, psychological intervention, as well as control of pain and alcohol consumption, should be considered to prevent the negative effects of cortisol secretion dysregulation in cancer patients.
format Online
Article
Text
id pubmed-9216328
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92163282022-06-24 Predisposing factors for increased cortisol levels in oral cancer patients Figueira, Jéssica Araújo Sarafim-Silva, Bruna Amélia Moreira Gonçalves, Gislene Maria Aranha, Laerte Nivaldo Lopes, Flávia Lombardi Corrente, José Eduardo Biasoli, Éder Ricardo Miyahara, Glauco Issamu Bernabé, Daniel Galera Compr Psychoneuroendocrinol Clinical Science Cancer patients may have a dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and abnormal secretion of cortisol. Increased cortisol levels have been associated with worse prognosis in patients with different types of tumors. Although anxiety and depression can trigger an abnormal cortisol secretion, little is known regarding the influence of these emotional disorders on HPA axis dysregulation in cancer patients when evaluating together with demographic, clinicopathological and biobehavioral variables. This cross-sectional study analyzed the pre-treatment plasma cortisol levels of 133 patients with oral squamous cell carcinoma (OSCC) and its association with demographic, clinicopathological, biobehavioral and psychological variables. Plasma cortisol levels were measured by electrochemiluminescence, and anxiety and depression symptoms were assessed using Beck Anxiety Inventory (BAI) and Depression (BDI), respectively. Demographic, clinicopathological and biobehavioral data were collected from patients' medical records. Results from multivariate analysis showed that the occurrence of cancer-induced pain was predictive for higher cortisol levels (OR = 5.388, p = 0.003). Men with OSCC were 4.5 times more likely to have higher plasma cortisol levels than women (OR = 4.472, p = 0.018). The effect of sex on cortisol concentrations was lost in the adjusted model for clinical staging (OR = 2.945, p = 0.116). The absence of chronic alcohol consumption history was a protective factor for highest hormone concentrations in oral cancer patients (OR = 0.104, p = 0.004). Anxiety symptoms measured by BAI as “hands trembling” (OR = 0.192, p = 0.016) and being “nervous” (OR = 0.207, p = 0.0004) were associated with lower cortisol levels. In contrast, the feeling of “fear of losing control” was a risk factor for highest hormone concentrations (OR = 6.508, p = 0.0004). The global score and specific symptoms of depression measured by the BDI were not predictive for plasma hormone levels (p > 0.05). Together, our results show that pain, alcohol consumption and feeling fear are independent factors for increased systemic cortisol levels in patients with oral cancer. Therefore, psychological intervention, as well as control of pain and alcohol consumption, should be considered to prevent the negative effects of cortisol secretion dysregulation in cancer patients. Elsevier 2022-01-06 /pmc/articles/PMC9216328/ /pubmed/35755918 http://dx.doi.org/10.1016/j.cpnec.2022.100110 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical Science
Figueira, Jéssica Araújo
Sarafim-Silva, Bruna Amélia Moreira
Gonçalves, Gislene Maria
Aranha, Laerte Nivaldo
Lopes, Flávia Lombardi
Corrente, José Eduardo
Biasoli, Éder Ricardo
Miyahara, Glauco Issamu
Bernabé, Daniel Galera
Predisposing factors for increased cortisol levels in oral cancer patients
title Predisposing factors for increased cortisol levels in oral cancer patients
title_full Predisposing factors for increased cortisol levels in oral cancer patients
title_fullStr Predisposing factors for increased cortisol levels in oral cancer patients
title_full_unstemmed Predisposing factors for increased cortisol levels in oral cancer patients
title_short Predisposing factors for increased cortisol levels in oral cancer patients
title_sort predisposing factors for increased cortisol levels in oral cancer patients
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216328/
https://www.ncbi.nlm.nih.gov/pubmed/35755918
http://dx.doi.org/10.1016/j.cpnec.2022.100110
work_keys_str_mv AT figueirajessicaaraujo predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT sarafimsilvabrunaameliamoreira predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT goncalvesgislenemaria predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT aranhalaertenivaldo predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT lopesflavialombardi predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT correntejoseeduardo predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT biasoliederricardo predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT miyaharaglaucoissamu predisposingfactorsforincreasedcortisollevelsinoralcancerpatients
AT bernabedanielgalera predisposingfactorsforincreasedcortisollevelsinoralcancerpatients